• 🌎 Worldwide
    • 🇺🇸 U.S.
    • 🇨🇦 Canada
    • 🇬🇧 United Kingdom
    • 🌏 Asia
    • 🌍 Europe
    • 🌎 Latin America
    • 🌏 Oceania and Australasia
The Daily Marijuana Observer
SUBSCRIBE
  • Home
  • Latest
  • Business
  • Investments
  • Law
  • People
  • Health
  • Databases
No Result
View All Result
The Daily Marijuana Observer
  • Home
  • Latest
  • Business
  • Investments
  • Law
  • People
  • Health
  • Databases
No Result
View All Result
The Daily Marijuana Observer
No Result
View All Result
Home Investments Press Releases

Emerald Organic Products Completes Successful Hand Sanitizer Product Pilot

Emerald Organic Products to Continue Research and Development of its Innovative Hand Sanitizer to Disrupt $2.7 Billion Industry

Globe Newswire by Globe Newswire
April 30, 2020
in Investments, Marijuana Stocks, Press Releases, United States
NxGen Hand Sanitizer for COVID-19 and Coronavirus Spread Prevention

Photo Credit - Emerald Organic Products Inc. / Globe Newswire

100
SHARES
ShareShare

Holbrook, NY, April 30, 2020 (GLOBE NEWSWIRE) — Emerald Organic Products, Inc. (OTC: EMOR) (the “Company”, “Emerald”, “Emerald Organic”, or “Emerald Organic Products”) a diversified health sciences and technology company, is pleased to announce that the Company has successfully completed its product pilot for NxGen Hand Sanitizer (the “Product Pilot”), selling out thousands of bottles within one week of launch.

“The great reception we received from the market for our NxGen hand sanitizer Product Pilot tells us that we are in the right sector, with the right product,” commented Ian Parker, Chief Executive Officer of Emerald Organic Products. “We know now that Emerald will be aggressively pursuing this important and timely market opportunity.”

According to a recent report from Grand View Research (the “Grand View Research Report”), the global hand sanitizer market was valued at $2.7 billion USD in 2019, with certain segments of the market estimated to grow at a compound annual growth rate (“CAGR”) of over 20%.

“Given the current state of public health in the United States and around the world, sanitization products are rapidly becoming adopted as a new mainstay within the personal health and hygiene categories,” continued Ian Parker. “Building upon the Product Pilot, Emerald Organic Products intends to initiate further sanitizer research and development in efforts to disrupt an otherwise dormant product category.”

Alarming results cited within the Grand View Research Report showed that 23% of the population covered in a survey claim to not to use hand sanitizer products.

“The estimated 23% of people that do not use hand sanitizer products pose a potential risk to public health. As public health officials continue to deal with the COVID-19 pandemic, increased education and awareness surrounding proper hand hygiene is of the utmost importance,” added Ian Parker. “In trying to restrict the spread of coronavirus, hand hygiene is quickly becoming an increasingly important pillar of personal care for many people.”

About Emerald Organic Products

Based in New York, Emerald Organic Products, Inc. (EMOR), is a diversified health sciences and technology company focused on providing consumers with one of the most robust health and wellness offerings available today. Through its subsidiaries, Emerald is dedicated to both bringing to market, and improving access to, holistic and FDA-regulated products and services. These include high-quality dietary supplements and hemp derived CBD products from its flagship brands Zenavita and Pura Vida Vitamins. In addition, EMOR will provide healthcare professionals with a full suite of solutions to transform healthcare through the lenses of convenience and mobility for the patient. In October 2019, Emerald Organic Products established Emerald Organic Life Sciences, LLC. to develop biopharmaceutical assets licensed from Amarantus Bioscience Holdings, Inc. (OTC: AMBS). On March 24, 2020, Emerald Organic Products announced a joint venture with Todos Medical USA, Inc. (OTC: TOMDF) for the purpose of distributing certain novel coronavirus (COVID-19) test kits. On March 27, 2020, Emerald Organic Products announced that it had signed a Plan of Merger Agreement with Bonsa Health, a leading digital pharmacy capable of same day delivery of Rx medications anywhere in the United States. On March 31, 2020, Emerald Organic Products Announced the signing of a definitive agreement to acquire Carie Health Inc., a leading telehealth and virtual care technology and service solutions company.

For more information, please visit emerald-organic.com.

Forward-looking Statement

Certain statements contained in this press release may constitute forward-looking statements. For example, forward-looking statements are used when discussing our expected clinical development programs and clinical trials. These forward-looking statements are based only on current expectations of management, and are subject to significant risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements, including the risks and uncertainties related to the progress, timing, cost, and results of clinical trials and product development programs; difficulties or delays in obtaining regulatory approval or patent protection for product candidates; competition from other biotechnology companies; and our ability to obtain additional funding required to conduct our research, development and commercialization activities. In addition, the following factors, among others, could cause actual results to differ materially from those described in the forward-looking statements: changes in technology and market requirements; delays or obstacles in launching our clinical trials; changes in legislation; inability to timely develop and introduce new technologies, products and applications; lack of validation of our technology as we progress further and lack of acceptance of our methods by the scientific community; inability to retain or attract key employees whose knowledge is essential to the development of our products; unforeseen scientific difficulties that may develop with our process; greater cost of final product than anticipated; loss of market share and pressure on pricing resulting from competition; and laboratory results that do not translate to equally good results in real settings, all of which could cause the actual results or performance to differ materially from those contemplated in such forward-looking statements. Except as otherwise required by law, Emerald Organic Products, Inc. does not undertake any obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

Share this:

  • Click to email this to a friend (Opens in new window)
  • Click to share on Twitter (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Reddit (Opens in new window)
  • Click to share on Telegram (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to share on Pinterest (Opens in new window)
  • Click to share on Tumblr (Opens in new window)
  • Click to share on Pocket (Opens in new window)
Tags: COVID-19Emerald Organic Products Inc.OTC:EMOR

Get Real-Time Updates from MJobserver.com

Unsubscribe
Globe Newswire

Globe Newswire

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Related Posts

Health Canada Licensed Cannabis Producer and Processor Stocks
Press Releases

Lexaria Bioscience Applies for NIH Grant for COVID-19 Therapy Studies and Receives New Expanded Health Canada License

June 18, 2020
Sanitizing and Disinfecting Spray
Business

Emerald Organic Products Launches Emerald Shield™ Division Alongside Nationwide Reopening and ‘Second Wave’ of Coronavirus

June 18, 2020
Cannabis Clinical Trials
Health

Drug Trial Planned For Synthetic Cannabinoid COVID-19 Treatment

June 8, 2020
Cannabis Stocks Going Up Today
Trading

5 of Today’s Biggest Cannabis Stock Gainers on Friday, June 5, 2020

June 5, 2020
Cannabis Stocks on the Rise Today
Trading

5 of Today’s Biggest Cannabis Stock Gainers on Thursday, June 4, 2020

June 4, 2020
CBD Hand Sanitizer News
Investments

7 CBD Stocks Capitalizing on Coronavirus Demand for Hand Sanitizer

June 4, 2020
Load More
Next Post
Bank of America Merrill Lynch Marijuana Stock Research Coverage

GW Pharmaceuticals to Present at the Bank of America Healthcare Conference 2020

Leave a Comment! Cancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

🚨 Subscribe to Stock Alerts

Get Live Updates on Breaking News

Subscribe Now

✉️ Subscribe to Our Newsletter!

* indicates required

🔎 Search Marijuana Stocks

📰 Recent News

  • Verano Holdings Enters into Agreement to Expand Arizona Footprint
  • Green Thumb Industries Announces Initial Public Offering in the U.S. to Raise US$100,000,000
  • Greenlane Announces Dismissal of Remaining Securities Class Action
  • Indiva Reports Record Market Share for January 2021
  • Acreage Announces Fourth Quarter And Full Year 2020 Earnings Date
Facebook Twitter Instagram LinkedIn Youtube

Cannabis News by Region

  • 🇺🇸 United States
  • 🇨🇦 Canada
  • 🇬🇧 United Kingdom
  • 🌏 Asia
  • 🌍 Europe
  • 🌎 Latin America
  • 🌏 Oceania and Australasia

Cannabis Tools & Resources

  • 📅 Calendar
  • 📊 Databases
  • 📇 Directories
  • 🔔 RSS Feeds
  • 📺 Videos

Find Cannabis Business Services

  • ⚖️ Attorneys & Law Firms
  • 📊 Accountants & Accounting Firms
  • 💡 Consultants & Consulting Firms
  • 📲 Marketing Agencies & Firms

The Daily Marijuana Observer

  • Subscribe
  • About MJobserver.com
  • Affiliate Marketing Disclosure
  • Legal Disclaimer
  • Privacy Policy
  • Contact Us

Advertise with Us

  • 👀 Advertise
  • 📣 DMO Newswire
  • 📇 List in Our Databases

© 2018 - 2021 D.M.O. Holdings Corp.
DISCLAIMER: DMO Holdings Corp., which owns The Daily Marijuana Observer™ (MJobserver.com), is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. DMO Holdings Corp., which owns MJobserver.com, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. DMO Holdings Corp. or its affiliates, which owns MJobserver.com, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two.

No Result
View All Result
  • Home
  • Latest
  • 🔒 PRO
    • 🔒 A.M. Watchlist
    • 🔒 Analyst Action
  • 💼 Business
  • 📈 Investments
    • 📈 Stocks
    • 💰 ETFs and Funds
    • 💭 Market Commentary
    • 📰 Press Releases
    • 📅 Earnings Calendar
  • ⚖️ Law
    • Laws
    • Politics
    • Intellectual Property
    • Attorneys & Law Firms Database
  • 👥 People
    • ⚽ Athletes
    • 💼 Executives
    • 🌟 Celebrities
    • 🛒 Consumers
    • ⚕️ Doctors
    • 💊 Patients
  • 💊 Health
  • 📇 Databases
    • 📈 Stock Databases
    • 💰 Fund Databases
    • 💼 Service Providers Databases
    • 🏦 Marijuana Stock Brokers
    • 💲 Marijuana Cryptocurrencies

© 2018 - 2021 D.M.O. Holdings Corp.
DISCLAIMER: DMO Holdings Corp., which owns The Daily Marijuana Observer™ (MJobserver.com), is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. DMO Holdings Corp., which owns MJobserver.com, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. DMO Holdings Corp. or its affiliates, which owns MJobserver.com, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two.

Login to your account below

Forgotten Password? Sign Up

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.